Physician profile
Mark C Margiotta
NPI 1295898674
$12,204.94
in general payments reported to CMS, 2019-2025
25 companies · $2,662 in 2025
The $2,662 reported for 2025 was more than what 88% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,472 · 2020: $116 · 2021: $286 · 2022: $321 · 2023: $2,750 · 2024: $1,599 · 2025: $2,662.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,663 · Travel and Lodging: $1,348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,663.07 |
| Travel and Lodging | $1,347.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,690.86 | 2019-2025 | Augment Injectable, Ortholoc 3di, Anchorage |
| Smith+Nephew, INC. | $1,555.05 | 2022-2025 | Grafix Pl, Stravix Pl, Stravix |
| Bioventus LLC | $1,310.90 | 2023 | Stimrouter Implantable Kit |
| Curonix LLC | $827.30 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medtronic, INC. | $362.16 | 2024-2025 | Inceptiv, Intellis Adaptivestim |
| Abbott Laboratories | $357.07 | 2022-2024 | Proclaim |
| Flower Orthopedics Coporation | $241.55 | 2021-2025 | |
| Treace Medical Concepts, INC. | $227.83 | 2025 | |
| Osiris Therapeutics INC. | $203.93 | 2019 | |
| Biowound Solutions, INC. | $197.35 | 2025 | Bio-Connekt |
| Wright Medical Technology, INC. | $194.18 | 2019 | |
| Tactile Systems Technology INC | $188.91 | 2022-2024 | Entre Plus, Flexitouch Plus |
| Abbvie INC. | $174.89 | 2023-2024 | |
| Averitas Pharma INC. | $148.97 | 2023-2024 | Qutenza |
| Mimedx Group, INC. | $144.12 | 2024 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Solutions INC | $85.00 | 2024 | |
| Orthofix Medical, INC. | $80.56 | 2019-2025 | Physio-Stim |
| Nevro Corp. | $63.50 | 2022-2023 | Senza |
| Kerecis Limited | $31.12 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Angiodynamics, INC. | $25.10 | 2024 | Venacure 1470 Pro |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $24.89 | 2025 | Jublia |
| Globus Medical, INC. | $24.43 | 2025 | Senza |
| Paragon 28, INC. | $17.68 | 2024 | Bun-Yo-Matic |
| Janssen Pharmaceuticals, INC | $15.16 | 2023 | Xarelto |
| Organogenesis INC. | $12.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Margiotta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.